ArticlePharmaceutical statistics

A Bayesian Dynamic Model-Based Adaptive Design for Oncology Dose Optimization in Phase I/II Clinical Trials.

Yingjie Qiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.